A comprehensive guide for healthcare professionals on managing hepatitis C in thalassemia patients, from epidemiology to treatment.
Introduction of this book:
Thalassemia patients have a high prevalence of hepatitis C virus (HCV) infections. Recent improvements in their survival are due to better iron overload control, safer blood transfusions, and improved complication management. Today, liver disease is the main cause of mortality in thalassemia patients worldwide. Unfortunately, most thalassemia centers lack adequate policies for controlling HCV infections. Thalassemia patients with HCV pose a management challenge and require professional counseling and appropriate diagnostic and therapeutic options. This book provides comprehensive guidance for health professionals on the epidemiology, screening, diagnosis, and treatment of HCV in this high-risk group, aiming to improve HCV control in thalassemia patients globally, especially in the Mediterranean region.
CHAPTER 1:
07 Virology
CHAPTER 2:
12 Epidemiology
CHAPTER 3:
26 Natural History
CHAPTER 4:
34 Diagnosis and evaluation
CHAPTER 5:
42 Treatment
Book Details:
- Author: Dr. Seyed-Moayed Alavian
- Publisher: Pouyan Kowsar Health Publishing Company; 1st edition ( April 8, 2022)
- Publication Date: April 8, 2022
- Print Length: 78 pages
- Language: English
- ISBN: 978-622-99114-6-4
- Sponsored by: Salamat Pooyan
Links and Copyrights:
- Amazon: https://www.amazon.com/dp/B08L1C3YHP
- Scinews
- Official Website
- PDF: https://services.brieflands.com/cdn/serve/315e2/a3c58ca53b56d2ed0272a74fe22e46de2216439e/From%20A%20to%20Z%20on%20Hepatitis%20C%20in%20Thalasemia%20(1).pdf
- Copyright: This book is published freely under only for personal use and not commercial use. We reserved Creative Commons Attribution Non-Commercial 4.0 International License.
- Ask for permission from the Publisher.
- Link to Table of Contents (Persian)